MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2016.08.014

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2016

Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.

Forconi Catherine, Gatault Philippe, Miquelestorena-Standley Elodie, Noble Johan, Al-Hajj Sally, Guillemain Romain, Stern Marc, Hoffmann Thomas, Prat Louis, Suberbielle Caroline, Masson Emeline, Cesbron-Gautier Anne, Gaudy-Graffin Catherine, Goudeau Alain, Thibault Gilles, Ivanes Fabrice, Guibon Roseline, Kazma Ihab, Lebranchu Yvon, Büchler Matthias, Magnan Antoine, Halimi Jean-Michel, Baron Christophe

Сравнительное исследованиеСтатьяПеревод в очереди

Аннотация

BACKGROUND

Cytomegalovirus (CMV) has a role in chronic rejection and graft loss in kidney transplant (KTx) and lung transplant (LTx) recipients. In addition, donor CMV seropositivity is an independent risk factor for renal graft loss. The anti-CMV response might modulate this risk. Expression of programmed cell death 1 (PD-1), a receptor involved in viral-specific T-cell exhaustion, is influenced by a single nucleotide polymorphism called PD-1.3 (wild-type allele G, variant allele A).

METHODS

We performed a retrospective study to assess the impact of PD-1.3 on graft outcome in donor CMV seropositive (D+) and donor CMV seronegative (D-) KTx and LTx. We also performed a case-control study to evaluate the anti-CMVpp65 response according to genotype.

RESULTS

PD-1.3 was determined in 1,119 KTx and 181 LTx. In 481 D+ KTx, A allele carriers (24%) experienced significantly less graft failure compared with GG carriers (p = 0.001). Multivariate analysis showed that this association was independent of donor and recipient age, acute rejection episodes, and number of human leukocyte antigen mismatches (hazard ratio, 0.381; 95% confidence interval, 0.209-0.696; p = 0.002). Analysis in 85 D+ LTx showed similar results: A allele carriers had better survival (hazard ratio, 0.302; 95% confidence interval, 0.128-0.716; p = 0.006) and greater 6-month forced expiratory volume (71% ± 17% vs 54% ± 16%, p = 0.001). In D- recipients, PD-1.3 did not affect KTx or LTx outcome. Finally, AA recipients had a stronger anti-CMVpp65 T-cell response than matched GG recipients (p = 0.003).

CONCLUSIONS

The A variant allele in PD-1.3 single nucleotide polymorphism improved graft survival in kidney and lung transplant recipients receiving grafts from CMV-positive donors.

Для цитирования: Forconi Catherine, Gatault Philippe, Miquelestorena-Standley Elodie, Noble Johan, Al-Hajj Sally, Guillemain Romain, Stern Marc, Hoffmann Thomas, Prat Louis, Suberbielle Caroline, Masson Emeline, Cesbron-Gautier Anne, Gaudy-Graffin Catherine, Goudeau Alain, Thibault Gilles, Ivanes Fabrice, Guibon Roseline, Kazma Ihab, Lebranchu Yvon, Büchler Matthias, Magnan Antoine, Halimi Jean-Michel, Baron Christophe. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2016. DOI: 10.1016/j.healun.2016.08.014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.